Reata Pharmaceuticals, Inc. Stock
Equities
RETA
US75615P1030
Biotechnology & Medical Research
Latest transcript on Reata Pharmaceuticals, Inc.
Managers | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director of Finance/CFO | 60 | 23-09-25 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director/Board Member | - | 23-09-25 | |
Michael Dambach
BRD | Director/Board Member | - | 23-09-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 773 M€ | -.--% | - | |
0.04% | 509 M€ | -.--% |
1st Jan change | Capi. | |
---|---|---|
-3.10% | 102B | |
+2.11% | 96.07B | |
-1.80% | 21.66B | |
-17.75% | 20.77B | |
-6.91% | 18.53B | |
-42.00% | 16.91B | |
-28.19% | 13.79B | |
+0.18% | 13.33B | |
+19.90% | 10.94B |